Install
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. VIEW ALL FEATURED COMPANIES VIEW ALL FEATURED COMPANIES VIEW ALL FEATURED COMPANIES V
- 339articles · 30d
- 2+ day agolatest article
- Aug 17, 2026earliest in window
- 92%with images
- 291avg words
- Economy, Business & Finance 195
- Health & Wellness 158
- Medical 157
- Business & Industrial 142
- Finance & Business 132
- Health 74
- Science & Technology 53
- Science & Nature 34
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Alkermes Announces Launch of 9th Annual Alkermes Pathways Research Awards® Program
3+ day, 5+ hour ago (88+ words) — Competitive Grant Program to Offer Individual Grants of Up to $100,000 per Project — — Areas of Interest Expanded to Include Narcolepsy and Idiopathic Hypersomnia in Addition to Schizophrenia and Bipolar I Disorder — — Stage One Submission Period Runs From Sept. 11, 2026 Through Oct. 16, 2026 — Alkermes…...
Stoke Therapeutics to Present at the Cantor Global Healthcare Conference
1+ week, 4+ day ago (290+ words) BioSpace Stoke Therapeutics to Present at the Cantor Global Healthcare Conference BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a…...
NeoGenomics to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
1+ week, 5+ day ago (118+ words) BioSpace NeoGenomics to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that the Company will participate in…...
Calluna Pharma Announces Participation in Upcoming Scientific and Investor Conferences
1+ week, 5+ day ago (209+ words) Company to highlight Phase 2 AURORA study of CAL101 in IPF ahead of planned Q1 2027 readout European Respiratory Society (ERS) Congress 2026 Barcelona, Spain Sept. 5–9, 2026 Jonas Hallen, M.D., Ph.D. (CMO) and Toby Maher, M.D., Ph.D. (Coordinating Investigator on the AURORA study) will…...
Omnicell to Present at the Wells Fargo 21st Annual Healthcare Conference
1+ week, 5+ day ago (130+ words) BioSpace Omnicell to Present at the Wells Fargo 21st Annual Healthcare Conference FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq:OMCL), a leading healthcare technology provider focused on empowering autonomous medication management, announced that it will present at the Wells Fargo…...
Seaport Therapeutics to Present at Citi’s 2026 Biopharma Back to School Conference and Participate in 21st Annual Wells Fargo Healthcare Conference
1+ week, 6+ day ago (213+ words) BioSpace Seaport Therapeutics to Present at Citi’s 2026 Biopharma Back to School Conference and Participate in 21st Annual Wells Fargo Healthcare Conference BOSTON--(BUSINESS WIRE)--Seaport Therapeutics, Inc. (Nasdaq: SPTX) (“Seaport” or the “Company”), a clinical-stage therapeutics company that is inventing and…...
Lōkahi Therapeutics™ Initiates Clinical Trial Manufacturing for LT-100
2+ week, 5+ day ago (299+ words) BioSpace Lōkahi Therapeutics™ Initiates Clinical Trial Manufacturing for LT-100 One year of work focused on one goal: manufacturing clinical material to enable once-weekly dosing RUTHERFORD, N.J. & LA JOLLA, Calif.--(BUSINESS WIRE)--Lōkahi Therapeutics™ Inc., a subsidiary of Glucotrack, Inc....
PICI Invests More Than $1 Million in Five Early Career Researchers Advancing the Future of Cancer Immunotherapy
3+ week, 4+ day ago (151+ words) PICI has now awarded more than $23.9 million total to fund 63 research projects in the last decade, powering the next generation of cancer immunotherapies Now in its tenth year, PICI's Early Career Researcher Awards program has invested $23.9 million across 63 research projects....
Revelation Biosciences Selects Avance Clinical as CRO for Phase 2/3 TITAN Study
3+ week, 4+ day ago (354+ words) BioSpace Revelation Biosciences Selects Avance Clinical as CRO for Phase 2/3 TITAN Study – Study on track to begin later this year – SAN DIEGO--(BUSINESS WIRE)--$REVB #AKI--Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company…...